Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance

Journal: Nature Communications

Published: 2018-10-17

DOI: 10.1038/s41467-018-06860-4

Affiliations: 17

Authors: 20

Go to article
Institutions FC
CAS Key Laboratory of Tissue Microenvironment and Tumour, SIBS CAS, China 0.21
University of Chinese Academy of Sciences (UCAS), Shanghai, China 0.21
Zhongshan Hospital, Fudan University, China 0.15
Institute of Health Sciences (IHS), SIBS CAS / SJTUSM, China 0.06
Department of Central Laboratory at Shanghai Tenth People's Hospital, Tongji University, China 0.05
MOE Key Laboratory of Medical Cell Biology, CMU, China 0.05
Department of Surgery and Cancer, ICL, United Kingdom (UK) 0.05
Institutes of Biomedical Sciences (IBS), Fudan University, China 0.03
Shanghai Key Laboratory of Breast Cancer, FUSCC Fudan University, China 0.03
Cancer Institutes, Fudan University, China 0.03
Institutes of Biology and Medical Sciences (IBMS), Soochow University, China 0.03
Medical College, Soochow University, China 0.03
UCSF Department of Laboratory Medicine, United States of America (USA) 0.03
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.03
VA Puget Sound Health Care System (VAPSHCS), United States of America (USA) 0.01
University of Washington (UW), United States of America (USA) 0.01